Daily Market Updates: Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

ETFs & Funds

Home›ETFs & Funds›Equity Funds›Blood clots are ‘incredibly common,’ even for pro athl…

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

Reported · Written up by our desk · Equity Funds

Research has found that it can take more than six months for professional athletes to return to play after being treated for a deep-vein thrombosis or pulmonary embolism.

← Newer storyLA Developers Eye 2029 Groundbreakings As High Costs Stall New Projec…Older story →Strive Buys $335 Million in Bitcoin After Investors Pour In $369 Mill…

More like this

ETFs & FundsNetflix vows to revive viewership trends, but investors hit ‘sell’ on the stock

ETFs & FundsBull markets tend to peak with a whimper, not a bang , but a 15% correction for the S&P 500 may be next

ETFs & FundsInflation Calls for Real Assets & Global Infrastructure

ETFs & FundsA Sterling Thesis: The Long-Term Silver Investment Case

ETFs & FundsApplying RAFI’s Multi-Factor Strategy to Global Markets

Sources

MarketWatchBlood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

ETFs & Funds

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

More like this

Sources

Get the close, explained.